Kanga Rani

Dr. Kanga Rani


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2019 in Biomolecules
Verified
Journal Article
Open access
PDF file
SSShonia Subramaniam
Shonia Subramaniam
KRKanga Rani
Kanga Rani
ARAmmu Kutty Radhakrishnan
Ammu Kutty Radhakrishnan
Cancer is a devastating disease that has claimed many lives. Natural bioactive agents from plants are gaining wide attention for their anticancer activities. Several studies have found that natural plant-based bioactive compounds can enhance the efficacy of chemotherapy, and in some cases ameliorate some of the side-effects of drugs used as chemotherapeutic agents. In this paper, we have reviewed the literature on the anticancer effects of four plant-based bioactive compounds namely, curcumin, myricetin, geraniin and tocotrienols (T3) to provide an overview on some of the key findings that are related to this effect. The molecular mechanisms through which the active compounds may exert their anticancer properties in cell and animal-based studies also discussed.

1 May 2004 in Lipids
Verified
Journal Article
Closed access
PDF file
KNKalanithi Nesaretnam
Kalanithi Nesaretnam
RARoberto Ambra
Roberto Ambra
KRKanga Rani
Kanga Rani
ARAmmu Radhakrishnan
Ammu Radhakrishnan
KRKarin Reimann
Karin Reimann
Fabio VirgiliFabio Virgili
Fabio Virgili

8 October 2010 in Breast Cancer Research
Verified
Journal Article
Open access
PDF file
KNKalanithi Nesaretnam
Kalanithi Nesaretnam
KRKanga Rani
Kanga Rani
GRGhazali Abdul Razak
Ghazali Abdul Razak
SVSheela Devi Veerasenan
Sheela Devi Veerasenan
PGPatricia A Gomez
Patricia A Gomez
Basic research has indicated that tocotrienols have potent antiproliferative and proapoptotic effects that would be expected to reduce the effect of breast cancer.

16 April 2009 in Nutrition and Cancer
Verified
Journal Article
Closed access
WWWong Weng-Yew
Wong Weng-Yew
KRKanga Rani
Kanga Rani
CMCheng Hwee Ming
Cheng Hwee Ming
KNKalanithi Nesaretnam
Kalanithi Nesaretnam
Previous studies have revealed that tocotrienol-rich fractions (TRF) from palm oil inhibit the proliferation and the growth of solid tumors. The anticancer activity of TRF is said to be caused by several mechanisms, one of which is antiangiogenesis. In this study, we looked at the antiangiogenic effects of TRF. In vitro investigations of the antiangiogenic activities of TRF, δ -tocotrienol ( δ T3), and α -tocopherol ( α Toc) were carried out in human umbilical vein endothelial cells (HUVEC). TRF and δ T3 significantly inhibited cell proliferation from 4 μ g/ml onward ( P < 0.05). Cell migration was inhibited the most by δ T 3 at 12 μ g/ml. Anti-angiogenic properties of TRF were carried out further in vivo using the chick embryo chorioallantoic membrane (CAM) assay and BALB/c mice model. TRF at 200 μ g/ml reduced the vascular network on CAM. TRF treatment of 1 mg/mouse significantly reduced 4T1 tumor volume in BALB/c mice. TRF significantly reduced serum vascular endothelial growth factor (VEGF) level in BALB/c mice. In conclusion, this study showed that palm tocotrienols exhibit anti-angiogenic properties that may assist in tumor regression.

19 March 2013 in Cell Proliferation
Verified
Journal Article
Closed access
RLR. Loganathan
R. Loganathan
KRKanga Rani
Kanga Rani
KNK. Nesaretnam
K. Nesaretnam
ARAmmu Kutty Radhakrishnan
Ammu Kutty Radhakrishnan

24 April 2011 in Genes & Nutrition
Verified
Journal Article
Closed access
PDF file
KNKalanithi Nesaretnam
Kalanithi Nesaretnam
PMPuvaneswari Meganathan
Puvaneswari Meganathan
SVSheela Devi Veerasenan
Sheela Devi Veerasenan
KRKanga Rani
Kanga Rani